STAT+: AbbVie dramatically boosts its spending on lobbying

WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

Continue to STAT+ to read the full story…

Read Original Article: STAT+: AbbVie dramatically boosts its spending on lobbying »